1. Home
  2. CWCO vs FBRX Comparison

CWCO vs FBRX Comparison

Compare CWCO & FBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Consolidated Water Co. Ltd.

CWCO

Consolidated Water Co. Ltd.

HOLD

Current Price

$29.48

Market Cap

514.1M

Sector

Utilities

ML Signal

HOLD

Logo Forte Biosciences Inc.

FBRX

Forte Biosciences Inc.

HOLD

Current Price

$16.87

Market Cap

487.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CWCO
FBRX
Founded
1973
N/A
Country
Cayman Islands
United States
Employees
N/A
N/A
Industry
Water Supply
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
514.1M
487.2M
IPO Year
1997
2017

Fundamental Metrics

Financial Performance
Metric
CWCO
FBRX
Price
$29.48
$16.87
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$40.00
$67.00
AVG Volume (30 Days)
82.4K
205.1K
Earning Date
05-11-2026
05-14-2026
Dividend Yield
1.73%
N/A
EPS Growth
N/A
61.30
EPS
0.23
N/A
Revenue
$132,073,368.00
$36,000.00
Revenue This Year
$4.34
N/A
Revenue Next Year
$42.86
N/A
P/E Ratio
$130.43
N/A
Revenue Growth
N/A
N/A
52 Week Low
$26.90
$9.12
52 Week High
$39.12
$35.80

Technical Indicators

Market Signals
Indicator
CWCO
FBRX
Relative Strength Index (RSI) 35.80 28.04
Support Level $28.17 $10.50
Resistance Level $34.26 $17.00
Average True Range (ATR) 0.79 1.97
MACD 0.14 -0.34
Stochastic Oscillator 50.20 1.82

Price Performance

Historical Comparison
CWCO
FBRX

About CWCO Consolidated Water Co. Ltd.

Consolidated Water Co Ltd is a water utility company. It develops and operates seawater desalination plants and water distribution systems. The company's business segments are; The retail segment operates the water utility for the Seven Mile Beach and West Bay areas of Grand Cayman Island, The bulk segment supplies potable water to government utilities in Grand Cayman and The Bahamas under long-term contracts, The services segment designs, constructs and sells water infrastructure and provides management and operating services to third parties. The manufacturing segment manufactures and services a wide range of custom and specialized water-related products applicable to commercial, municipal, and industrial water production, supply, and treatment, and the corporate segment.

About FBRX Forte Biosciences Inc.

Forte Biosciences Inc is a clinical-stage biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary anti-CD122 monoclonal antibody therapeutic candidate with potentially broad autoimmune and autoimmune-related indications. The Company is also advancing clinical development of FB102 in patient-based trials for non-segmental vitiligo and alopecia areata.

Share on Social Networks: